Drug Development Linked More Closely to Diagnostics

Pharmaceutical Technology, Pharmaceutical Technology-10-02-2004, Volume 28, Issue 10

FDA and industry discuss proposals for regulating combination diagnostics, medical devices, and pharmacogenomic-based drug products.

Related Content:

FormulationProcess ValidationQuality SystemsRegulatory WatchDevelopmentPharmaceutical Technology-10-02-2004